Palisade Bio (PALI) Cash from Investing Activities Growth (1y) (2011 - 2021)
Palisade Bio (PALI) Cash from Investing Activities Growth (1y) (2011 - 2021) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 62.68% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | -674.01% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -166.24% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Palisade Bio | 424.57 Mn | 291.94 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | -34,900.00% |
| Dec 31, 2018 | -320.10% |
| Dec 31, 2017 | 99.99% |
| Dec 31, 2016 | -97.06% |
| Jun 30, 2016 | -8.61% |
| Mar 31, 2016 | 7,721.50% |
| Dec 31, 2015 | -3,258.65% |
| Sep 30, 2015 | 10,607.29% |
| Jun 30, 2015 | 45.19% |
| Mar 31, 2015 | 99.35% |
| Dec 31, 2014 | 17.64% |
| Sep 30, 2014 | 54.09% |
| Jun 30, 2014 | -20.42% |
| Mar 31, 2014 | -15,623.64% |
| Dec 31, 2013 | -38.76% |
| Sep 30, 2013 | -436.20% |
| Jun 30, 2013 | -16.43% |
| Mar 31, 2013 | -236.54% |
| Dec 31, 2012 | -9.46% |
| Sep 30, 2012 | 70.83% |